KELLI LAMB: Open Payments
NPI 1427394345 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,227 in 149 payments from 15 companies in 2025. Trend: 2023 $2,144 · 2024 $2,726 · 2025 $3,227
Food & beverage: $3,227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $701 |
| Madrigal Pharmaceuticals | 26 | $638 |
| Janssen Biotech, Inc. | 23 | $434 |
| Phathom Pharmaceuticals, Inc. | 16 | $398 |
| GENZYME CORPORATION | 9 | $186 |
| Aimmune Therapeutics, Inc. | 8 | $157 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $156 |
| Lilly USA, LLC | 7 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $115 |
| Ardelyx, Inc. | 5 | $97 |
Products named: REZDIFFRA, TREMFYA, VOQUEZNA, LINZESS, DUPIXENT, RINVOQ, ZENPEP, XIFAXAN.
Industry payments across FL — which companies pay providers there.
